Molecular Fingerprint of Precancerous Lesions in Breast Atypical Hyperplasia.
Chao Zheng,Hong Ying Jia,Li Yuan Liu,Qi Wang,Hong Chuan Jiang,Li Song Teng,Cui Zhi Geng,Feng Jin,Li,Jian Guo Zhang,Xiang Wang,Shu Wang,Fernandez-Escobar Alejandro,Fei Wang,Li Xiang Yu,Fei Zhou,Yu Juan Xiang,Shu Ya Huang,Qin Ye Fu,Qiang Zhang,De Zong Gao,Zhong Bing Ma,Liang Li,Zhi Min Fan,Zhi Gang Yu
DOI: https://doi.org/10.1177/0300060520931616
2020-01-01
Journal of International Medical Research
Abstract:Objective To identify atypical hyperplasia (AH) of the breast by shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS), and to explore the molecular fingerprinting characteristics of breast AH. Methods Breast hyperplasia was studied in 11 hospitals across China from January 2015 to December 2016. All patients completed questionnaires on women’s health. The differences between patients with and without breast AH were compared. AH breast lesions were detected by Raman spectroscopy followed by the SHINERS technique. Results There were no significant differences in clinical features and risk-related factors between patients with breast AH (n = 37) and the control group (n = 2576). Fifteen cases of breast AH lesions were detected by Raman spectroscopy. The main different Raman peaks in patients with AH appeared at 880, 1001, 1086, 1156, 1260, and 1610 cm−1, attributed to the different vibrational modes of nucleic acids, β-carotene, and proteins. Shell-isolated nanoparticles had different enhancement effects on the nucleic acid, protein, and lipid components in AH. Conclusion Raman spectroscopy can detect characteristic molecular changes in breast AH lesions, and may thus be useful for the non-invasive early diagnosis and for investigating the mechanism of tumorigenesis in patients with breast AH.